Europe Transradial Access Market Analysis By Top Vendors Like Cardinal Health, Stryker, CARDINAL HEALTH, Angiodynamics and More During Forecast Period of 2018-2025

Europe Transradial Access Market is expected to reach USD 546.8 Million by 2025 from USD 288.6 Million in 2017, at a CAGR of 8.4% in the forecast period 2018 to 2025.
The major factors driving the growth of this market are increasing cases of obese patient, rising number of heart problems, growing use of radial access in oncology field and technological advancements are the factors which will boost the Europe transradial access market.

Europe transradial access market is expected to USD 546.8 Million by 2025 from USD 288.6 Million in 2017, at a CAGR of 8.4% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

To request a free sample copy or view summary of this report, click the link below: http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-transradial-access-market

Covered in this report

The report covers the present scenario and the growth prospects of the Europe transradial access for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Key market players for Europe transradial access market are listed below:

  • BD
  • Terumo Corporation
  • Teleflex Incorporated
  • Smiths Group plc
  • MEDTRONIC
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Merit Medical Systems Inc.
  • NIPRO CORPORATION, ANGIODYNAMICS INC.
  • Amecath
  • OSCOR Inc.
  • Penumbra
  • Stryker
  • CARDINAL HEALTH

Have Any Query? Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-transradial-access-market

The market is further segmented into:

  • Product
  • Application
  • Usage
  • End User

The Europe transradial access market is segmented based on product into six notable segments; sheaths and sheath introducers, mircrocatheters, guidewires, guiding catheters, intermediate catheters and accessories. In 2018, sheaths and sheath introducers market is likely to dominate market with 30.0% shares and is estimated to reach USD 173.9 million by 2025. It is growing at the highest CAGR of 9.3% in the forecast period.

The Europe transradial access market is segmented based on application into three notable segments; neurovascular, cardiology, and peripheral vascular. In 2018, cardiology market will dominate with 46.9% shares and will consume around USD 268.1 million by 2025. It is growing at the highest CAGR of 9.1% in the assessment period.

The Europe transradial access market is segmented based on usage into four notable segments; drug administration, fluid and nutrition administration, diagnostics and testing and blood transfusion. In 2018, the drug administration market is estimated to dominate market with 36.3% shares and will collect around USD 210.5 million by 2025, rising with the highest CAGR of 9.3%.

The Europe transradial access market is segmented based on end user into four notable segments; hospital, clinics, ambulatory care centers and others. In 2018, hospitals market is expected to dominate market with 41.7% shares and is estimated to reach USD 238.7 million by 2025, growing at the highest CAGR of 9.1%.

Based on geography, the market is segmented into:

  • Germany
  • France
  • U.K.
  • Spain
  • Italy
  • Switzerland
  • Netherlands
  • Russia
  • Turkey
  • Belgium
  • Rest of Europe

Get 10% discount on this report Click Here @ http://databridgemarketresearch.com/reports/europe-transradial-access-market/

 

Table of Content:

1

INTRODUCTION

1.1

OBJECTIVES OF THE STUDY

1.2

MARKET DEFINITION

1.3

OVERVIEW OF EUROPE TRANSRADIAL ACCESS MARKET

1.4

CURRENCY AND PRICING

1.5

LIMITATION

1.6

MARKETS COVERED

2

MARKET SEGMENTATION

2.1

MARKETS COVERED

2.2

GEOGRAPHIC SCOPE

2.3

YEARS CONSIDERED FOR THE STUDY

2.4

CURRENCY AND PRICING

2.5

RESEARCH METHODOLOGY

2.6

PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7

SECONDARY SOURCES

2.8

ASSUMPTIONS

3

MARKET OVERVIEW

3.1

DRIVERS

3.1.1

INCREASING CASES OF OBESE PATIENTS

3.1.2

RISING NUMBER OF HEART PROBLEMS

3.1.3

GROWING USE OF RADIAL ACCESS IN ONCOLOGY FIELD

3.1.4

TECHNOLOGICAL ADAVANCEMENTS

3.2

RESTRAINTS

3.2.1

PRODUCT RECALLS AND FAILURES

3.3

OPPORTUNITIES

3.3.1

EMERGING MARKETS

3.4

CHALLENGES

3.4.1

SIDE EFFECTS OF TRANSRADIAL ACCESS

3.4.2

LACK OF SKILLED PROFESSSIONALS

4

EXECUTIVE SUMMARY

5

PREMIUM INSIGHTS

6

EUROPE TRANSRADIAL ACCESS MARKET, BY PRODUCT

6.1

OVERVIEW

6.2

SHEATHS AND SHEATH INTRODUCERS

6.3

MIRCROCATHETERS

6.4

GUIDEWIRES

6.5

GUIDING CATHETERS

6.6

INTERMEDIATE CATHETERS

6.7

ACCESSORIES

7

EUROPE TRANSRADIAL ACCESS MARKET, BY APPLICATION

7.1

OVERVIEW

7.2

CARDIOLOGY

7.3

PERIPHERAL VASCULAR

7.4

NEUROVASCULAR

8

EUROPE TRANSRADIAL ACCESS MARKET, BY USAGE

8.1

OVERVIEW

8.2

DRUG ADMINISTRATION

8.3

FLUID AND NUTRITION ADMINISTRATION

8.4

DIAGNOSTICS AND TESTING

8.5

BLOOD TRANSFUSION

9

EUROPE TRANSRADIAL ACCESS MARKET, BY END USER

9.1

OVERVIEW

9.2

HOSPITAL

9.3

CLINICS

9.4

AMBULATORY CARE CENTERS

9.5

OTHERS

10

EUROPE TRANSRADIAL ACCESS SYSTEM MARKET, BY GEOGRAPHY

10.1

EUROPE

10.1.1

GERMANY

10.1.2

FRANCE

10.1.3

U.K.

10.1.4

ITALY

10.1.5

SPAIN

10.1.6

SWITZERLAND

10.1.7

NETHERLANDS

10.1.8

TURKEY

10.1.9

BELGIUM

10.1.10

RUSSIA

10.1.11

REST OF EUROPE

11

EUROPE TRANSRADIAL ACCESS MARKET,  COMPANY LANDSCAPE

11.1

COMPANY SHARE ANALYSIS: EUROPE

12

COMPANY PROFILES

12.1

CARDINAL HEALTH

12.1.1

COMPANY OVERVIEW

12.1.2

REVENUE ANALYSIS : CARDINAL HEALTH

12.1.3

PRODUCT PORTFOLIO

12.1.4

RECENT DEVELOPMENTS RECENT DEVELOPMENTS

12.2

STRYKER

12.2.1

COMPANY OVERVIEW

12.2.2

REVENUE ANALYSIS: STRYKER

12.2.3

PRODUCT PORTFOLIO

12.2.4

RECENT DEVELOPMENTS

12.3

ANGIODYNAMICS INC

12.3.1

COMPANY OVERVIEW

12.3.2

REVENUE ANALYSIS : ANGIODYNAMICS INC

12.3.3

PRODUCT PORTFOLIO

12.3.4

RECENT DEVELOPMENTS

12.4

BD

12.4.1

COMPANY OVERVIEW

12.4.2

REVENUE ANALYSIS : BD

12.4.3

PRODUCT PORTFOLIO

12.4.4

RECENT DEVELOPMENTS

12.5

AMECATH

12.5.1

COMPANY OVERVIEW

12.5.2

COMPANY SNAPSHOT: AMECATH

12.5.3

PRODUCT PORTFOLIO

12.5.4

RECENT DEVELOPMENTS

12.6

BOSTON SCIENTIFIC CORPORATION

12.6.1

COMPANY OVERVIEW

12.6.2

REVENUE ANALYSIS : BOSTON SCIENTIFIC CORPORATION

12.6.3

PRODUCT PORTFOLIO

12.6.4

RECENT DEVELOPMENTS

12.7

EDWARDS LIFESCIENCES CORPORATION

12.7.1

COMPANY OVERVIEW

12.7.2

REVENUE ANALYSIS : EDWARDS LIFESCIENCES CORPORATION

12.7.3

PRODUCT PORTFOLIO

12.7.4

RECENT DEVELOPMENTS

12.8

MEDTRONIC

12.8.1

COMPANY OVERVIEW

12.8.2

REVENUE ANALYSIS : MEDTRONIC

12.8.3

PRODUCT PORTFOLIO

12.8.4

RECENT DEVELOPMENTS

12.9

MERIT MEDICAL SYSTEMS INC.

12.9.1

COMPANY OVERVIEW

12.9.2

REVENUE ANALYSIS: MERIT MEDICAL SYSTEMS INC.

12.9.3

PRODUCT PORTFOLIO

12.9.4

RECENT DEVELOPMENTS

12.10

NIPRO CORPORATION

12.10.1

COMPANY OVERVIEW

12.10.2

REVENUE ANALYSIS : NIPRO CORPORATION

12.10.3

PRODUCT PORTFOLIO

12.10.4

RECENT DEVELOPMENTS

12.11

OSCOR INC

12.11.1

COMPANY OVERVIEW

12.11.2

COMPANY SNAPSHOT: OSCOR INC:

12.11.3

RODUCT PORTFOLIO

12.11.4

RECENT DEVELOPMENTS

12.12

PENUMBRA

12.12.1

COMPANY OVERVIEW

12.12.2

REVENUE ANALYSIS: PENUMBRA

12.12.3

PRODUCT PORTFOLIO

12.12.4

RECENT DEVELOPMENTS

12.13

SMITHS GROUP PLC

12.13.1

COMPANY OVERVIEW

12.13.2

REVENUE ANALYSIS : SMITHS GROUP PLC

12.13.3

PRODUCT PORTFOLIO

12.13.4

RECENT DEVELOPMENTS

12.14

TELEFLEX INCORPORATED

12.14.1

COMPANY OVERVIEW

12.14.2

REVENUE ANALYSIS : TELEFLEX INCORPORATED

12.14.3

PRODUCT PORTFOLIO

12.14.4

RECENT DEVELOPMENTS

12.15

TERUMO CORPORATION

12.15.1

COMPANY OVERVIEW

12.15.2

REVENUE ANALYSIS : TERUMO CORPORATION

12.15.3

PRODUCT PORTFOLIO

12.15.4

RECENT DEVELOPMENTS RECENT DEVELOPMENTS

13

RELATED REPORTS

For customisation in report, Ask Our Experts http://databridgemarketresearch.com/speak-to-analyst/?dbmr=europe-transradial-access-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/europe-transradial-access-market/